Jing Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jing Zhou has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Andrew R Snyder
The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA
1 shared publication- Daming Zuo
Institute of Molecular Immunology, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Province Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China
1 shared publication - Jia Zhou
Department of Immunology, Guangdong Province Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
1 shared publication Jian Cui
Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publication- Na Zhao
Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education; School of Basic Medical Sciences, Gannan Medical University, Ganzhou, China
1 shared publication - Paul M. Lieberman
The Wistar Institute
1 shared publication
Latest Publications
- Open Access
- 8 October 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-11
Intermittent Hypoxia Enhances THP-1 Monocyte Adhesion and Chemotaxis and Promotes M1 Macrophage Polarization via RAGE
Intermittent hypoxia (IH) that resulted from obstructive sleep apnea (OSA) has been found to be a risk factor of coronary artery disease. IH and the receptor for advanced glycation end products (RAGE) expression are known to activate monocyte/macrophage and associated with atherosclerosis development, while their effects on monocyte adhesion, chemotaxis to the endothelium, and macrophage polarization remain unknown. In the present study, RAGE in THP-1 monocytes was inhibited by shRNA lentiviral particles, followed by exposure to IH. Cell adhesion assay, transwell migration assay, and macrophage polarization assays were performed to study the effects of IH and RAGE. The mRNA and protein expression levels were investigated by RT/real-time PCR and western blot analysis, respectively. We found that IH increased RAGE expression and activated NF-кB signalling in THP-1 monocytes. The results also revealed that IH enhanced the MCP-1-mediated THP-1 monocyte adhesion and chemotaxis and promoted macrophage polarization toward a proinflammatory phenotype, which was mediated by RAGE activity. Additionally, inhibition of chemokine receptor type 2 (CCR2) suppressed the IH-induced monocyte adhesion and chemotaxis. These results demonstrated a potential role of monocyte adhesion, chemotaxis, and macrophage polarization in the development cardiovascular diseases induced by IH and identified that RAGE could be a promising therapeutic target to prevent atherosclerosis in patients with OSA.
- 8 October 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-11
Open AccessIntermittent Hypoxia Enhances THP-1 Monocyte Adhesion and Chemotaxis and Promotes M1 Macrophage Polarization via RAGE
Intermittent hypoxia (IH) that resulted from obstructive sleep apnea (OSA) has been found to be a risk factor of coronary artery disease. IH and the receptor for advanced glycation end products (RAGE) expression are known to activate monocyte/macrophage and associated with atherosclerosis development, while their effects on monocyte adhesion, chemotaxis to the endothelium, and macrophage polarization remain unknown. In the present study, RAGE in THP-1 monocytes was inhibited by shRNA lentiviral particles, followed by exposure to IH. Cell adhesion assay, transwell migration assay, and macrophage polarization assays were performed to study the effects of IH and RAGE. The mRNA and protein expression levels were investigated by RT/real-time PCR and western blot analysis, respectively. We found that IH increased RAGE expression and activated NF-кB signalling in THP-1 monocytes. The results also revealed that IH enhanced the MCP-1-mediated THP-1 monocyte adhesion and chemotaxis and promoted macrophage polarization toward a proinflammatory phenotype, which was mediated by RAGE activity. Additionally, inhibition of chemokine receptor type 2 (CCR2) suppressed the IH-induced monocyte adhesion and chemotaxis. These results demonstrated a potential role of monocyte adhesion, chemotaxis, and macrophage polarization in the development cardiovascular diseases induced by IH and identified that RAGE could be a promising therapeutic target to prevent atherosclerosis in patients with OSA.
- 1 September 2016
- Published by Elsevier in Journal of Immunological Methods
- Vol. 436, 16-21
Development and evaluation of a double antibody sandwich ELISA for the detection of human sDC-SIGN
- 1 September 2016
- Published by Elsevier in Journal of Immunological Methods
- Vol. 436, 16-21
Development and evaluation of a double antibody sandwich ELISA for the detection of human sDC-SIGN
- Open Access
- 15 June 2009
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 8 (12) , 1136-1145
Therapeutic doses of Hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres
Hydroxyurea (HU) is a chemotherapeutic agent commonly used for various malignancies and hematological disorders, including chronic myelogenous leukemia and sickle cell anemia. We show here that chr...
- 15 June 2009
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 8 (12) , 1136-1145
Open AccessTherapeutic doses of Hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres
Hydroxyurea (HU) is a chemotherapeutic agent commonly used for various malignancies and hematological disorders, including chronic myelogenous leukemia and sickle cell anemia. We show here that chr...